Analysts have recently evaluated Humana and provided 12-month price targets. The average target is $280.75, accompanied by a ...

Valued at a market cap of $28 billion, Humana Inc. (HUM) is a leading U.S. health care plan provider offering medical and ...

Humana and S&P 500 Performance During 2007-08 Crisis HUM stock declined from $71 in September 2007 (pre-crisis peak) to $24 in March 2009 (as the markets bottomed out).

Humana Inc. (NYSE: HUM) is a leading health insurer predominantly focused on Medicare Advantage plans, serving millions of ...

Humana Inc.’s stock was up 2% Friday after three straight sessions of declines, but investors paying attention to the performance of its bonds on Thursday may have had something of a heads-up on ...

LOUISVILLE, Ky. — Louisville-based Humana saw its stock price take a big hit Wednesday after the healthcare company said a Medicare Advantage quality rating drop will impact future bonus ...

Steve Baxter has given his Buy rating due to a combination of factors reflecting Humana’s (HUM) solid performance and positive outlook.

This adjustment suggests confidence in Humana’s stock performance, particularly in light of recent share price appreciation linked to political factors that may favor the managed care industry.

Humana stock is spiraling Wednesday after the CMS provided preliminary Star Ratings data for the insurer's 2025 Medicare Advantage plans.

Humana and S&P 500 Performance During 2007-08 Crisis HUM stock declined from $71 in September 2007 (pre-crisis peak) to $24 in March 2009 (as the markets bottomed out).

Humana Inc.'s stock was up 2% Friday after three straight sessions of declines, but investors paying attention to the performance of its bonds on Thursday may have had something of a heads-up on ...